PMC:7228307 / 1385-1668 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"19","span":{"begin":0,"end":4},"obj":"Gene"},{"id":"25","span":{"begin":208,"end":214},"obj":"Chemical"}],"attributes":[{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Gene:2213"},{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"MESH:D011134"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"FcγR function and the complexity of the relationships between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” therapeutic antibodies. Such development strategies now include focused glycan or protein engineering of the Fc to increase affinity and/or tailor "}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T8","span":{"begin":218,"end":225},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"FcγR function and the complexity of the relationships between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” therapeutic antibodies. Such development strategies now include focused glycan or protein engineering of the Fc to increase affinity and/or tailor "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T15","span":{"begin":0,"end":2},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T16","span":{"begin":62,"end":64},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T17","span":{"begin":65,"end":67},"obj":"http://purl.obolibrary.org/obo/CLO_0008882"},{"id":"T18","span":{"begin":200,"end":207},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"},{"id":"T19","span":{"begin":245,"end":247},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"FcγR function and the complexity of the relationships between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” therapeutic antibodies. Such development strategies now include focused glycan or protein engineering of the Fc to increase affinity and/or tailor "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":218,"end":225},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"FcγR function and the complexity of the relationships between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” therapeutic antibodies. Such development strategies now include focused glycan or protein engineering of the Fc to increase affinity and/or tailor "}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T8","span":{"begin":5,"end":13},"obj":"http://purl.obolibrary.org/obo/BFO_0000034"}],"text":"FcγR function and the complexity of the relationships between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” therapeutic antibodies. Such development strategies now include focused glycan or protein engineering of the Fc to increase affinity and/or tailor "}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T2","span":{"begin":218,"end":225},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"FcγR function and the complexity of the relationships between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” therapeutic antibodies. Such development strategies now include focused glycan or protein engineering of the Fc to increase affinity and/or tailor "}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"19","span":{"begin":0,"end":4},"obj":"Gene"},{"id":"25","span":{"begin":208,"end":214},"obj":"Chemical"}],"attributes":[{"id":"A19","pred":"pubann:denotes","subj":"19","obj":"Gene:2213"},{"id":"A25","pred":"pubann:denotes","subj":"25","obj":"MESH:D011134"}],"text":"FcγR function and the complexity of the relationships between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” therapeutic antibodies. Such development strategies now include focused glycan or protein engineering of the Fc to increase affinity and/or tailor "}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T8","span":{"begin":218,"end":225},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"FcγR function and the complexity of the relationships between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” therapeutic antibodies. Such development strategies now include focused glycan or protein engineering of the Fc to increase affinity and/or tailor "}